Biomed & Biotech Firms - Publicly Traded*

Optimer Pharmaceuticals Inc.

Company Website

10110 Sorrento Valley Rd. Ste., C
San Diego, CA 92121

Sourcebook Data

View all the companies in Biomed & Biotech Firms - Publicly Traded*

Optimer Pharmaceuticals Inc.

Market Cap as of 6/12/2015

Market Cap as of 7/03/2014

Market Cap as of 07/02/2013

$709,374,878

Market Cap as of 06/26/2012

$702,049,683

Market Cap as of 01/04/2012

$556,011,400

Market Cap as of 06/20/2011

$578,909,100

Market Cap as of 01/06/2011

$445,855,000

Exchange and Ticker Symbol

Nasdaq: OPTR

Fields of Research

Development and commercialization of pharmaceutical products

Major Products

Fidaxomicin tablets, Solithromycin, OPT-822/821

Executives

Pedro Lichtinger

  • Chief Executive Officer
  • President